Tango Therapeutics, Inc. (TNGX)
TNGX has a market cap or net worth of $726.64 million. The enterprise value is $227.73 million.
TNGX has 87.55 million shares outstanding. The number of shares has increased by 100.06% in one year.
|Shares Change (YoY)||+100.06%|
|Shares Change (QoQ)||+384.34%|
|Owned by Insiders (%)||15.47%|
|Owned by Institutions (%)||74.87%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 12.30, with a Debt / Equity ratio of 0.02.
|Debt / Equity||0.02|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||n/a|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||n/a|
|Profits Per Employee||n/a|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -18.23% in the last 52 weeks.
|52-Week Price Change||-18.23%|
|50-Day Moving Average||10.15|
|200-Day Moving Average||11.75|
|Average Volume (30 Days)||168,912|
Short Selling Information
|Short % of Shares Out||2.63%|
|Short % of Float||5.30%|
|Short Ratio (days to cover)||14.02|
|Earnings Per Share (EPS)||-$1.52|
The company has $506.08 million in cash and $7.18 million in debt, giving a net cash position of $498.90 million or $5.70 per share.
|Cash & Cash Equivalents||506.08M|
|Net Cash Per Share||$5.70|
|Book Value Per Share||4.17|
|Operating Cash Flow||n/a|
|Free Cash Flow||n/a|
|FCF Per Share||n/a|
Dividends & Yields
TNGX does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|